Pandolfi, Franco
 Distribuzione geografica
Continente #
NA - Nord America 5.588
AS - Asia 3.740
EU - Europa 3.288
SA - Sud America 737
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 75
OC - Oceania 20
Totale 13.540
Nazione #
US - Stati Uniti d'America 5.452
SG - Singapore 1.819
CN - Cina 929
DE - Germania 885
BR - Brasile 622
SE - Svezia 533
UA - Ucraina 517
FR - Francia 325
IT - Italia 281
VN - Vietnam 246
IE - Irlanda 223
ID - Indonesia 137
FI - Finlandia 136
GB - Regno Unito 128
IN - India 124
RU - Federazione Russa 95
JP - Giappone 84
BD - Bangladesh 83
HK - Hong Kong 57
TR - Turchia 52
CA - Canada 50
AR - Argentina 43
IQ - Iraq 39
MX - Messico 39
PL - Polonia 33
BE - Belgio 25
NL - Olanda 25
ZA - Sudafrica 25
PK - Pakistan 23
SA - Arabia Saudita 23
AU - Australia 18
ES - Italia 16
CO - Colombia 15
JM - Giamaica 13
VE - Venezuela 13
KR - Corea 12
CL - Cile 11
UZ - Uzbekistan 11
EC - Ecuador 10
IR - Iran 10
MA - Marocco 10
PH - Filippine 10
CH - Svizzera 9
AZ - Azerbaigian 8
PY - Paraguay 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
JO - Giordania 7
KE - Kenya 7
UY - Uruguay 7
DZ - Algeria 6
KZ - Kazakistan 6
NP - Nepal 6
CZ - Repubblica Ceca 5
LB - Libano 5
MY - Malesia 5
PE - Perù 5
PR - Porto Rico 5
AL - Albania 4
AT - Austria 4
DK - Danimarca 4
EG - Egitto 4
LT - Lituania 4
MK - Macedonia 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
MM - Myanmar 3
MN - Mongolia 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BG - Bulgaria 2
BZ - Belize 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IS - Islanda 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
RE - Reunion 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
Totale 13.430
Città #
Singapore 883
Ashburn 702
Chandler 515
San Jose 509
Jacksonville 264
Dublin 215
San Mateo 214
Beijing 197
Wilmington 125
Jakarta 124
Nanjing 111
Ann Arbor 108
Lauterbourg 105
Boston 89
Hefei 89
Lawrence 89
Los Angeles 78
Hanoi 74
Cattolica 73
Dearborn 70
New York 66
Ho Chi Minh City 65
Houston 65
Moscow 63
Tokyo 63
Woodbridge 52
Boardman 47
Fairfield 47
Redwood City 47
Hong Kong 46
Frankfurt am Main 45
Dallas 44
Seattle 44
São Paulo 42
Detroit 39
Buffalo 38
Santa Clara 38
Chicago 36
Milan 36
Marseille 34
Mountain View 34
Helsinki 33
Kent 33
Nürnberg 33
Hangzhou 32
Lancaster 32
Nanchang 32
Shenyang 32
Munich 31
University Park 31
Rio de Janeiro 30
Hebei 29
Shanghai 29
Atlanta 27
Princeton 23
Rome 23
Izmir 22
Brooklyn 21
Brussels 20
Cambridge 20
Bremen 19
Guangzhou 19
Norwalk 19
Changsha 18
Jiaxing 18
Washington 18
Baghdad 17
The Dalles 16
Da Nang 15
Paris 15
Tianjin 15
Belo Horizonte 14
Jinan 14
Kraków 14
London 14
Memphis 14
Zhengzhou 14
Council Bluffs 13
Pune 13
Toronto 13
Fremont 12
Johannesburg 12
Tukwila 12
Ankara 11
Nuremberg 11
Stockholm 11
Warsaw 11
Brasília 10
Charlotte 10
Dhaka 10
Düsseldorf 10
Kingston 10
Philadelphia 10
Phoenix 10
Simi Valley 10
Tashkent 10
Curitiba 9
Denver 9
Jeddah 9
Kunming 9
Totale 6.676
Nome #
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 336
Strategies to overcome obstacles to successful immunotherapy of melanoma 253
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 242
Can vitamin a mediate immunity and inflammation? 193
Impact of mast cells in rejection of allografts 192
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 177
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 168
Interleukin-6 in Rheumatoid Arthritis 168
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 166
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 164
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 163
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 158
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 154
Reflux symptoms in wind instrument players. 153
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 151
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 150
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 149
IL-32: a newly-discovered proinflammatory cytokine 148
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 147
The immune response to tumors as a tool toward immunotherapy 146
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 146
Role of vitamins D, E and C in immunity and inflammation. 146
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 142
Third-line rescue therapy for Helicobacter pylori infection 139
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 138
New insights on the role of T-cels in the pathogenesis of Celiac Disease 137
New insights on the role of T cells in the pathogenesis of celiac disease. 137
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 137
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 133
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 133
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 132
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 131
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 131
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 130
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 129
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 128
Interrelationship between IL-3 and mast cells 127
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 127
Third-line rescue therapy for Helicobacter pylori infection. 121
Impact of IL-18 on inflammation 121
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 120
Activity of caffeic acid derivatives against Candida albicans biofilm 119
TLR2: a crossroads between infections and autoimmunity? 119
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 117
Current Challenges in Immunology 116
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 116
TLR2: a crossroads between infections and autoimmunity? 114
Luteolin inhibits mast cell-mediated allergic inflammation. 114
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 113
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 113
Impact of Fungi on Immune Responses 113
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 112
VEGF, substance P and stress, new aspects: a revisited study. 111
Strategies to overcome obstacles to successful immunotherapy of melanoma. 110
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 110
Mast cell involvement in rheumatoid arthritis. 110
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 109
Impairment of recent thymic emigrants in HCV infection. 109
The impact of biological agents interfering with receptor/ligand binding in the immune system. 108
Role of mast cells in innate and adaptive immunity. 108
High prevalence of hyperplastic colonic polyps in acromegalic subjects 107
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 107
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 105
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 104
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 102
Abnormal synthesis of IgA in coeliac disease and related disorderd 101
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 101
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 100
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 98
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 97
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 97
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 97
IL-31 a Th2 cytokine involved in immunity and inflammation. 97
Involvment of central immunity in uncomplicated diverticular disease. 97
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 95
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 94
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 94
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 93
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 92
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 92
Impact of mast cells on the skin. 91
Nerve growth factor interactions with mast cells 91
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 90
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 89
Active thymopoiesis in idiopathic chronic pancreatitis 87
Vitamins and mast cells. 87
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 86
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 85
Impact of IL -9 and IL-33 in mast cells 85
Interrelationship between IL-3 and mast cells 85
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 84
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 84
Psychological stress and vitamins 84
Epatite da farmaci 83
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 81
Impact of neuropeptide substance P an inflammatory compound on arachidonic acid compound generation 81
IL-36 receptor antagonist with special emphasis on IL-38. 80
Allergic inflammation: role of cytokines with special emphasis on IL-4 79
IgE generation and mast cell activation 79
Nutrition and cancer prevention 79
Totale 12.164
Categoria #
all - tutte 57.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022816 0 128 15 63 47 34 11 127 39 44 118 190
2022/20231.587 233 182 156 207 156 203 55 94 166 44 60 31
2023/2024918 30 284 25 129 27 107 23 44 21 39 93 96
2024/20251.646 46 72 146 38 107 51 18 112 298 114 325 319
2025/20264.333 702 132 301 411 697 206 732 215 273 349 176 139
2026/2027845 180 665 0 0 0 0 0 0 0 0 0 0
Totale 13.540